|
Code
|
Display
|
Definition
|
|
NACHC.A0.DE1
|
Encounter Type |
Encounter Type |
|
NACHC.A1.DE1
|
HIV Diagnosis |
HIV Diagnosis |
|
NACHC.A2.DE1
|
HIV Test |
HIV Test |
|
NACHC.A2.DE216
|
HIV Test Ordered |
HIV Test Ordered |
|
NACHC.B1.DE1
|
Hepatitis C Diagnosis |
Hepatitis C Diagnosis |
|
NACHC.B2.DE1
|
Hepatitis C Test |
Hepatitis C Test |
|
NACHC.B2.DE103
|
Antinuclear antibodies (ANA) |
Hepatitis C Test - Antinuclear antibodies (ANA) |
|
NACHC.B2.DE104
|
Hepatitis C antibody |
Hepatitis C Test - Hepatitis C antibody |
|
NACHC.B2.DE105
|
Hepatitis C antibody; confirmatory test (eg, immunoblot) |
Hepatitis C Test - Hepatitis C antibody; confirmatory test (eg, immunoblot) |
|
NACHC.B2.DE106
|
Infectious agent detection by nucleic acid (DNA or RNA); hepatitis C, direct probe technique |
Hepatitis C Test - Infectious agent detection by nucleic acid (DNA or RNA); hepatitis C, direct probe technique |
|
NACHC.B2.DE107
|
Infectious agent detection by nucleic acid (DNA or RNA); hepatitis C, amplified probe technique, includes reverse transcription when performed |
Hepatitis C Test - Infectious agent detection by nucleic acid (DNA or RNA); hepatitis C, amplified probe technique, includes reverse transcription when performed |
|
NACHC.B2.DE108
|
Infectious agent detection by nucleic acid (DNA or RNA); hepatitis C, quantification, includes reverse transcription when performed |
Hepatitis C Test - Infectious agent detection by nucleic acid (DNA or RNA); hepatitis C, quantification, includes reverse transcription when performed |
|
NACHC.B2.DE109
|
Infectious agent genotype analysis by nucleic acid (DNA or RNA); Hepatitis C virus |
Hepatitis C Test - Infectious agent genotype analysis by nucleic acid (DNA or RNA); Hepatitis C virus |
|
NACHC.B2.DE112
|
Hepatitis C Procedures |
Hepatitis C Procedures |
|
NACHC.B2.DE113
|
RNA testing for Hepatitis C documented as performed within 6 months prior to initiation of antiviral treatment for Hepatitis C (HEP-C) |
Hepatitis C Procedures - RNA testing for Hepatitis C documented as performed within 6 months prior to initiation of antiviral treatment for Hepatitis C (HEP-C) |
|
NACHC.B2.DE114
|
Hepatitis C quantitative RNA testing documented as performed at 12 weeks from initiation of antiviral treatment (HEP-C) |
Hepatitis C Procedures - Hepatitis C quantitative RNA testing documented as performed at 12 weeks from initiation of antiviral treatment (HEP-C) |
|
NACHC.B2.DE115
|
Ribonucleic acid (RNA) testing for Hepatitis C viremia ordered or results documented (HEP C) |
Hepatitis C Procedures - Ribonucleic acid (RNA) testing for Hepatitis C viremia ordered or results documented (HEP C) |
|
NACHC.B2.DE116
|
Hepatitis C genotype testing documented as performed prior to initiation of antiviral treatment for Hepatitis C (HEP C) |
Hepatitis C Procedures - Hepatitis C genotype testing documented as performed prior to initiation of antiviral treatment for Hepatitis C (HEP C) |
|
NACHC.B2.DE117
|
Hepatitis C screening documented as performed (HIV) |
Hepatitis C Procedures - Hepatitis C screening documented as performed (HIV) |
|
NACHC.B2.DE118
|
Patient receiving antiviral treatment for Hepatitis C (HEP-C) |
Hepatitis C Procedures - Patient receiving antiviral treatment for Hepatitis C (HEP-C) |
|
NACHC.B2.DE119
|
Collection of venous blood by venipuncture |
Hepatitis C Procedures - Collection of venous blood by venipuncture |
|
NACHC.B2.DE120
|
Infectious disease, chronic hepatitis C virus (HCV) infection, six biochemical assays (ALT, A2-macroglobulin, apolipoprotein A-1, total bilirubin, GGT, and haptoglobin) utilizing serum, prognostic algorithm reported as scores for fibrosis and necroinflammatory activity in liver |
Hepatitis C Procedures - Infectious disease, chronic hepatitis C virus (HCV) infection, six biochemical assays (ALT, A2-macroglobulin, apolipoprotein A-1, total bilirubin, GGT, and haptoglobin) utilizing serum, prognostic algorithm reported as scores for fibrosis and necroinflammatory activity in liver |
|
NACHC.C1.DE1
|
Syphilis Diagnosis |
Syphilis Diagnosis |
|
NACHC.C2.DE1
|
Syphilis Test |
Syphilis Test |
|
NACHC.D1.DE1
|
Gonorrhea Diagnosis |
Gonorrhea Diagnosis |
|
NACHC.D2.DE1
|
Gonorrhea Test |
Gonorrhea Test |
|
NACHC.E1.DE1
|
Chlamydia Diagnosis |
Chlamydia Diagnosis |
|
NACHC.E2.DE1
|
Chlamydia Test |
Chlamydia Test |
|
NACHC.F1.DE1
|
Drug Rehabilitation |
Drug Rehabilitation |
|
NACHC.F1.DE12
|
Injection Findings |
Injection Findings |
|
NACHC.F1.DE15
|
Injection Drug Use Diagnosis |
Injection Drug Use Diagnosis |
|
NACHC.F1.DE200
|
Injection Drug Use |
Injection Drug Use |
|
NACHC.F2.DE1
|
Pregnancy Encounters |
Pregnancy Encounters |
|
NACHC.F2.DE38
|
Third Trimester Encounters |
Third Trimester Encounters |
|
NACHC.F2.DE42
|
Pregnancy Supervision |
Pregnancy Supervision |
|
NACHC.F2.DE108
|
Maternal Care |
Maternal Care |
|
NACHC.F2.DE672
|
Pregnancy Procedures |
Pregnancy Procedures |
|
NACHC.F2.DE904
|
Pregnancy Observations |
Pregnancy Observations |
|
NACHC.F2.DE1131
|
Pregnancy Conditions |
Pregnancy Conditions |
|
NACHC.G1.DE1
|
Post Exposure Prophylaxis |
Post Exposure Prophylaxis |
|
NACHC.G1.DE5
|
PEP Medication Prescriptions |
PEP Medication Prescriptions |
|
NACHC.G1.DE143
|
PEP Dispensed Medications |
PEP Dispensed Medications |
|
NACHC.G2.DE1
|
Prep Medication Prescriptions |
Prep Medication Prescriptions |
|
NACHC.G2.DE26
|
Prep Dispensed Medications |
Prep Dispensed Medications |
|
NACHC.H1.DE1
|
Previous HIV Screening |
Previous HIV Screening |
|
NACHC.H1.DE2
|
Previous HIV Diagnosis |
Previous HIV Diagnosis |
|
NACHC.H1.DE3
|
Patient Currently Pregnant |
Patient Currently Pregnant |
|
NACHC.H1.DE4
|
Patient Diagnosed with HCV |
Patient Diagnosed with HCV |
|
NACHC.H1.DE5
|
Patient Diagnosed with Syphilis |
Patient Diagnosed with Syphilis |
|
NACHC.H1.DE6
|
Patient Diagnosed with Gonorrhea |
Patient Diagnosed with Gonorrhea |
|
NACHC.H1.DE7
|
Patient Diagnosed with Chlamydia |
Patient Diagnosed with Chlamydia |
|
NACHC.H1.DE8
|
Patient has used Injection Drugs |
Patient has used Injection Drugs |
|
NACHC.H1.DE9
|
Seeking STD Treatment |
Seeking STD Treatment |
|
NACHC.H1.DE10
|
Previous experience with PREP |
Previous experience with PREP |
|
NACHC.H1.DE11
|
Sexual Activity - Past Year |
Sexual Activity - Past Year |
|
NACHC.H1.DE12
|
Sexual Activity - History |
Sexual Activity - History |
|
NACHC.H1.DE13
|
Sexual Activity - Men |
Sexual Activity - Men |
|
NACHC.H1.DE14
|
Sexual Activity - Women |
Sexual Activity - Women |
|
NACHC.H1.DE15
|
Sexual Activity - Number of Partners |
Sexual Activity - Number of Partners |
|
NACHC.H1.DE16
|
Sexual Activity - New Partner Past 3 Months |
Sexual Activity - New Partner Past 3 Months |
|
NACHC.H1.DE17
|
Sexual Activity - Partners History |
Sexual Activity - Partners History |
|
NACHC.H1.DE18
|
Sexual Activity - Partners Number of Partners |
Sexual Activity - Partners Number of Partners |
|
NACHC.H1.DE19
|
Sexual Activity - Partners HIV History |
Sexual Activity - Partners HIV History |
|
NACHC.H1.DE20
|
Sexual Activity - Drug or Alcohol Use |
Sexual Activity - Drug or Alcohol Use |
|
NACHC.H1.DE21
|
Sexual Activity - Exchanged for Sex |
Sexual Activity - Exchanged for Sex |
|
NACHC.H1.DE22
|
Sexual Activity - Coercion |
Sexual Activity - Coercion |
|
NACHC.H1.DE23
|
Sexual Activity - Kind of Sex - Anal |
Sexual Activity - Kind of Sex - Anal |
|
NACHC.H1.DE24
|
Sexual Activity - Male - Kind of Sex - Receptive Anal |
Sexual Activity - Male - Kind of Sex - Receptive Anal |
|
NACHC.H1.DE25
|
Sexual Activity - Male - Kind of Sex - Insertive Anal |
Sexual Activity - Male - Kind of Sex - Insertive Anal |
|
NACHC.H1.DE26
|
Sexual Activity - Kind of Sex - Vaginal |
Sexual Activity - Kind of Sex - Vaginal |